Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaCerebrolysin

Cerebrolysin

Peptide preparation (porcine-derived)

Not ARTG-approved

What it is

A peptide preparation derived from pig brain tissue, used in some overseas markets for neurological conditions.

What the evidence shows

Evidence is mixed and debated; it is not an approved Australian medicine.

Safety & reported risks

As an unapproved injectable preparation, quality and oversight are the key concerns.

Status in Australia

Not ARTG-approved in Australia. Importing or supplying it for human use is not a lawful pathway.

How it’s lawfully accessed

No lawful consumer supply in Australia. Not on the ARTG.

Related peptides

DihexaAngiotensin-derived peptideResearch / unapprovedP21 (P021)NGF-derived peptideResearch / unapproved

Sources & further reading

This entry is general information about Cerebrolysin, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.